FDA approves new drug to prevent hereditary angioedema attacks.
Lavine
Greg
G
D054179:Angioedemas, Hereditary / Q000188:drug therapy / Q000503:physiopathology / Q000517:prevention & control*; D050718:Complement C1 Inhibitor Protein / Q000009:adverse effects / Q000627:therapeutic use*; D017277:Drug Approval; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D050718:Complement C1 Inhibitor Protein